Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina's Growth Vision 2024-03-06 12:29
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024 2024-03-06 08:59
AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting 2024-03-06 08:59
Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma 2024-03-06 08:45
Antengene to Present Four Preclinical Abstracts at AACR 2024, Highlighting Focus on Cancer Immunology, Targeted Agents and Novel Technology Platforms 2024-03-06 08:30
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024 2024-03-06 05:30
Datasea Expects Approximately 1,128% Revenue Growth in 2024 2024-03-05 23:45
Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production 2024-03-05 22:00
DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador 2024-03-05 22:00
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries 2024-03-05 21:00
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment 2024-03-05 21:00
IRBM Expands Global Reach in Drug Discovery with New Boston Office 2024-03-05 20:24
One Million Global Healthcare Seekers Embrace MedicalTourism.com: Medical Tourism Magazine Leads the Way 2024-03-05 16:00
Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer 2024-03-05 13:35
First Patient Treated in Phase 2 GvHD Trial 2024-03-05 10:08
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform 2024-03-05 07:01
Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery 2024-03-05 06:55
Cyient Partners with MassMedic to Accelerate MedTech Innovation 2024-03-04 22:00
Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024 2024-03-04 22:00
ACROBiosystems Launches New Initiative to Support Cell and Gene Manufacturers 2024-03-04 22:00
1 90 91 92 93 94 963